MGI Tech and SeqOne Partner to Advance End-to-End Genomic Analysis
MGI and SeqOne partner to develop genomic analysis solutions, combining MGI's sequencing tech with SeqOne's AI-powered platform.
News
January 30, 2024
SeqOne Genomics appoints Martin Dubuc as Chief Executive Officer
Martin Dubuc appointed as SeqOne Genomics CEO, Nicolas Philippe becomes President & CPSO to drive global clinical genomics expansion.
Platform features
April 19, 2024
SeqOne GenomeAlert! A variant reevaluation automation agent to improve patient care
GenomeAlert! reevaluates genetic variant classifications monthly against ClinVar to ensure accurate patient diagnoses and treatment.
Platform features
June 17, 2024
Introducing SeqOne CGH Array Interpretation
SeqOne Cloud now supports Agilent CGH MicroArrays, offering AI-powered CNV annotation, ACMG classification, and seamless Cartagenia migration.
Case study
October 14, 2024
Precision Medicine at Scale: AP-HM’s Automated Exome Analysis Success Story
APHM and SeqOne partner to automate exome sequencing with AI, processing up to 2,000 rare disease samples yearly for better diagnostics.
Case study
September 9, 2024
Case Study: North West GLH Validation and Implementation of In-House HRD testing with SeqOne’s SomaHRD
SeqOne’s HRD platform enables North West GLH to conduct in-house genomic instability testing for ovarian cancer.
Platform features
November 18, 2024
SeqOne’s DiagAI Score Brings Transparency to Genomic Variant Ranking: Unveiling the AI Decision Process with xAI
DiagAI uses inheritance & quality rules based on real diagnostic data, enabling clinicians to understand AI recommendations and collaborate on system improvement.
SeqOne launches DiagAI Score, a 0-100 metric for ranking genetic variants' disease-causing potential, combining AI power with human expertise for faster diagnosis.
Platform features
February 10, 2025
Next-Generation Phenotype-Driven Genomic Analysis with SeqOne
SeqOne's DiagAI HPO automates extraction of HPO terms from clinical notes using AI, streamlining phenotype-driven genomic analysis with multi-language support.